PAPA (Papa Medical) LT-Debt-to-Total-Asset: 0.07 (As of Mar. 2025)


What is Papa Medical LT-Debt-to-Total-Asset?

Papa Medical PAPA LT-Debt-to-Total-Asset is 0.07 as of Mar. 2025.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Papa Medical's long-term debt to total assests ratio for the quarter that ended in Mar. 2025 was 0.07.

Papa Medical's long-term debt to total assets ratio increased from Mar. 2024 (0.00) to Mar. 2025 (0.07). It may suggest that Papa Medical is progressively becoming more dependent on debt to grow their business.

Papa Medical  (NAS:PAPA) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Papa Medical LT-Debt-to-Total-Asset Related Terms

Papa Medical LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Papa Medical's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Papa Medical LT-Debt-to-Total-Asset Chart

Papa Medical Annual Data
Trend Dec22 Dec23 Dec24
LT-Debt-to-Total-Asset
0.06 0.09 0.08

Papa Medical Quarterly Data
Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only 0.00 0.13 0.12 0.08 0.07

Papa Medical LT-Debt-to-Total-Asset Calculation

Papa Medical's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )/Total Assets (A: Dec. 2024 )
=1.624/19.416
=0.08

Papa Medical's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2025 is calculated as

LT Debt to Total Assets (Q: Mar. 2025 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2025 )/Total Assets (Q: Mar. 2025 )
=1.34/19.672
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.07 mean?
Papa Medical (PAPA) has a LT-Debt-to-Total-Asset of 0.07 as of Mar. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Papa Medical and its competitors.
Is Papa Medical's LT-Debt-to-Total-Asset too high?
Papa Medical's current LT-Debt-to-Total-Asset is 0.07.
How does Papa Medical's LT-Debt-to-Total-Asset compare to ?
Papa Medical's LT-Debt-to-Total-Asset of 0.07 can be compared against companies in the Tobacco Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Tobacco Products company?
A good LT-Debt-to-Total-Asset depends on the Tobacco Products industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Papa Medical and its competitors. Papa Medical's current LT-Debt-to-Total-Asset is 0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Papa Medical stock overvalued right now?
Papa Medical (PAPA) has a current LT-Debt-to-Total-Asset of 0.07. The current LT-Debt-to-Total-Asset is 0.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Papa Medical (PAPA), the current LT-Debt-to-Total-Asset is 0.07 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Papa Medical Business Description

Comparable Companies
Address 202 North California Ave, City of Industry, CA, USA, 91744
Papa Medical Inc is the first end-to-end cannabis dosing solution provider in the U.S. that possesses the medical atomization or nebulizing background and sells nebulizers. The company deeply engages in key activities in the cannabis and consuming E-vapors industry, from research and development, formulation design, e-liquid production, and e-liquid filling to e-liquid co-packing services. It is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis E-vapors.